More than 10 thousand results were observed during May 2022 in tenders under the heading "health and medicines", ranging from medical treatments to equipment and machinery used in the health sector.
An analysis by CentralAmericaData's Business Intelligence department shows interesting data on the processes that during May 2022 were published with contracts to provide pharmaceuticals, equipment and medical supplies to the several Ministries of Health and Social Security entities in Central American countries and the Dominican Republic.
A cut-off for the first quarter of the year shows a relevant figure in the health and medicine sector for the Central American region and the Dominican Republic.
An analysis of CentralAmericaData's Business Intelligence department shows interesting data on the processes that in the first quarter of 2022 were published with contracts to supply pharmaceuticals, equipment and medical supplies to the various Ministries of Health and Social Security entities in Central American countries and the Dominican Republic.
During 2020, Central America's imports of pharmaceutical products containing insulin totaled $35 million, and purchases from Danish companies increased 11% over what was reported in 2019.
Figures from the Trade Intelligence Unit of CentralAmericaData: [GRAFICA caption="Click to interact with graphic"]
During 2020, companies in the region allocated $134 million for the import of vaccines for human use, and purchases from Russian companies increased 54% over what was reported in 2019.
Figures from the Trade Intelligence Unit of CentralAmericaData: [GRAFICA caption="Click to interact with the graph"]
The Ministry of Public Finances published the bases for four public tenders, through which the supply of pharmaceutical products to be used by the Ministry of Public Health will be contracted.
The four tenders are in the Open Contract Purchase modality for the supply and acquisition by the State of Medicinal and Pharmaceutical Products.
From January to September 2020, Central American imports of pharmaceutical products totaled $2.625 billion, an amount that exceeds by just 0.4% what was reported in the same period of 2019.
Figures from the Trade Intelligence Unit of CentralAmericaData: [GRAFICA caption="Click to interact with the graph"]
The business sector in Guatemala is anticipating an increase in the prices of food and medicines, due to the government's decision to raise the cost of procedures such as the issuance of licenses and health registrations, required to market these products.
By means of Government Agreement 179-2020, which entered into force on December 1, 2020, new fees were imposed for the services of procedures for licenses, registrations and other processes for medicines, laboratories, pharmaceuticals, food products and others.
Nicaragua, Costa Rica and Guatemala are the Central American markets that during the first half of 2020 and in year-on-year terms, increased their imports of pharmaceutical products.
Figures from the Trade Intelligence Unit of CentralAmericaData: [GRAFICA caption="Click to interact with graphic"]
From January to July 2020, purchases of pharmaceutical products made by Central American countries from Mexican companies totaled $174 million, 7% more than what was reported for the same period in 2019.
Figures from the Trade Intelligence Unit of CentralAmericaData: [GRAFICA caption="Click to interact with graphic"]
The business sector in Guatemala rejects the measure of the Ministry of Economy, which establishes maximum sales prices to the consumer for certain pharmaceutical products, while the state of disaster decreed by covid-19 lasts.
The Ministry of Economy of Guatemala issued an agreement establishing maximum sales prices to consumers for certain pharmaceutical products, while the state of calamity decreed by covid-19 lasts.
Arguing that the health of the nation's inhabitants is a public good and that institutions are required to ensure its conservation and restoration, the government will regulate the prices of several medicines.
From January to March 2020, pharmaceutical product imports in Central America totaled $825 million, with Costa Rica and Guatemala being the markets where purchases increased the most.
Figures from CentralAmericaData's Commercial Intelligence Unit: [GRAFICA caption="Click to interact with graphic"]
Productos Roche, Drogueria e Importadora Alemana and Corporacion Industrial Farmaceutica are some of the companies that during the first six months of the year won contracts to provide medicines and pharmaceutical products to public health institutions in the region.
The "Interactive Public Procurement Information System" of CentralAmericaData's Trade Intelligence Unit provides interesting data on the companies that in the first half of 2020 were favored with contracts to provide pharmaceutical products and medical supplies to the various Ministries of Health and Social Security entities in the Central American countries.
In the complex scenario of health crisis, companies in the pharmaceutical sector in Guatemala are facing shortages of raw materials, mainly those imported from the U.S., Europe and China.
In the context of the covid-19 outbreak, the pharmaceutical industry has kept alive and according to businessmen in the sector, the country's laboratories maintain their operations at an average of 70%.